These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 15297036

  • 1. D-serine-induced nephrotoxicity: possible interaction with tyrosine metabolism.
    Williams RE, Lock EA.
    Toxicology; 2004 Sep 01; 201(1-3):231-8. PubMed ID: 15297036
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
    Ellis MK, Whitfield AC, Gowans LA, Auton TR, Provan WM, Lock EA, Smith LL.
    Toxicol Appl Pharmacol; 1995 Jul 01; 133(1):12-9. PubMed ID: 7597701
    [Abstract] [Full Text] [Related]

  • 3. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat.
    Williams RE, Lock EA.
    Toxicology; 2005 Feb 01; 207(1):35-48. PubMed ID: 15590120
    [Abstract] [Full Text] [Related]

  • 4. Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat.
    Lock EA, Gaskin P, Ellis MK, Provan WM, Robinson M, Smith LL, Prisbylla MP, Mutter LC.
    Toxicol Appl Pharmacol; 1996 Dec 01; 141(2):439-47. PubMed ID: 8975769
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interaction of (4-hydroxyphenyl)pyruvate dioxygenase with the specific inhibitor 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione.
    Kavana M, Moran GR.
    Biochemistry; 2003 Sep 02; 42(34):10238-45. PubMed ID: 12939152
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tyrosinemia produced by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) in experimental animals and its relationship to corneal injury.
    Lock EA, Gaskin P, Ellis M, Provan WM, Smith LL.
    Toxicol Appl Pharmacol; 2006 Aug 15; 215(1):9-16. PubMed ID: 16580702
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
    Mitchell GA.
    Hum Exp Toxicol; 1996 Feb 15; 15(2):179-81. PubMed ID: 8645506
    [No Abstract] [Full Text] [Related]

  • 11. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
    Luijerink MC, van Beurden EA, Malingré HE, Jacobs SM, Grompe M, Klomp LW, Berger R, van den Berg IE.
    Kidney Int; 2004 Sep 15; 66(3):990-1000. PubMed ID: 15327392
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1.
    Langlois C, Jorquera R, Finegold M, Shroads AL, Stacpoole PW, Tanguay RM.
    Biochem Pharmacol; 2006 May 28; 71(11):1648-61. PubMed ID: 16581029
    [Abstract] [Full Text] [Related]

  • 13. Interference of hydroxyphenylpyruvic acid, hydroxyphenyllactic acid and tyrosine on routine serum and urine clinical chemistry assays; implications for biochemical monitoring of patients with alkaptonuria treated with nitisinone.
    Curtis SL, Norman BP, Milan AM, Gallagher JA, Olsson B, Ranganath LR, Roberts NB.
    Clin Biochem; 2019 Sep 28; 71():24-30. PubMed ID: 31228435
    [Abstract] [Full Text] [Related]

  • 14. From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug.
    Lock EA, Ellis MK, Gaskin P, Robinson M, Auton TR, Provan WM, Smith LL, Prisbylla MP, Mutter LC, Lee DL.
    J Inherit Metab Dis; 1998 Aug 28; 21(5):498-506. PubMed ID: 9728330
    [Abstract] [Full Text] [Related]

  • 15. Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) and its effect on enzymes involved in tyrosine catabolism in the mouse.
    Lock EA, Gaskin P, Ellis MK, McLean Provan W, Robinson M, Smith LL.
    Toxicology; 2000 Apr 03; 144(1-3):179-87. PubMed ID: 10781886
    [Abstract] [Full Text] [Related]

  • 16. Tyrosinemia I, a model for human diseases mediated by 2-oxoacid-utilizing dioxygenases: hepatotoxin suppression by NTBC does not normalize hepatic collagen metabolism.
    Hanauske-Abel HM, Popowicz A, Remotti H, Newfield RS, Levy J.
    J Pediatr Gastroenterol Nutr; 2002 Jul 03; 35(1):73-8. PubMed ID: 12142814
    [Abstract] [Full Text] [Related]

  • 17. A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria.
    Suzuki Y, Oda K, Yoshikawa Y, Maeda Y, Suzuki T.
    J Hum Genet; 1999 Jul 03; 44(2):79-84. PubMed ID: 10083729
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers.
    Hall MG, Wilks MF, Provan WM, Eksborg S, Lumholtz B.
    Br J Clin Pharmacol; 2001 Aug 03; 52(2):169-77. PubMed ID: 11488774
    [Abstract] [Full Text] [Related]

  • 19. Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.
    Al-Dhalimy M, Overturf K, Finegold M, Grompe M.
    Mol Genet Metab; 2002 Jan 03; 75(1):38-45. PubMed ID: 11825062
    [Abstract] [Full Text] [Related]

  • 20. From Weed Killer to Wonder Drug.
    Lock EA.
    Adv Exp Med Biol; 2017 Jan 03; 959():175-185. PubMed ID: 28755195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.